RespireRx Pharmaceuticals Inc (fka RSPI)

[ombowstring]

I was very disconcerted by the DARPA failure -- I had thought CX717 would prove to be a "smart pill" enhancing the cognitive faculties of anyone who tried it. Perhaps the downturn in the stock price is a factor of not knowing what we have here now. Will it work in ADHD? Will it work in schizophrenia patients? Will the high impacts prove to be efficacious?

I think if we had hit a home run in the DARPA trial, the stock price would reflect genuine and substantiated confidence in the AMPAKINE technology. Now we have to show efficacy in Phase II trials, I think, before the stock price reflects real confidence in the platform. Of course, a BP deal would cause a jump in the share price. On the other hand, if the BOD decides to do another PIPE, that would probably cut the share price down somewhat more.